Comparing Heart Scan and Traditional Risk Assessment for Statin Decisions

Digital opportunity (v4): Clinic Checklist for Comparing Statin Eligibility Methods Target users: Primary care clinics, cardiology practices, and healthcare teams seeking to evaluate or update their statin prescription protocols based on new evidence. How it would work: Develop a paper or digital checklist for clinics to record and compare statin recommendations using both traditional risk assessments and heart scan results for a sample of eligible patients. The checklist would include fields for risk score, scan findings, statin recommendation, and patient adherence follow-up. First version: A one-page checklist template (paper or spreadsheet) piloted by a nurse or clinician in a single clinic, used with up to 20 consenting adult patients undergoing cardiovascular risk assessment over one month. Alternatives to investigate: Existing electronic health record (EHR) tools, national guideline calculators, or commercial risk assessment apps. Compare usability, cost, and integration with current workflow. Difference to test: Whether the checklist enables clinics to track differences in statin recommendations and adherence between methods, and supports discussion about adopting new protocols. Source evidence of a capability or need: Major trial challenges how doctors decide who really needs statins A study of nearly 5,800 adults found that heart scans measuring calcium buildup in the arteries led to the same Possible uses and limits: Clinics may wish to compare or update their statin eligibility protocols in light of new evidence. The checklist helps document differences and supports local discussion, but does not replace guidelines or clinical expertise. Potential users and optional payers: Unverified analysis, not established facts; confirm before acting. No established paying customers; this is a non-commercial, quality improvement tool for clinics. No monetization required for pilot. Competitors and alternatives to check: Unverified analysis, not established facts; confirm before acting. National guideline calculators, EHR-based risk tools, and commercial apps may offer similar functions. Usability and workflow integration should be compared locally. Optional legal business model: Proposed hypothesis; revenue may never occur. No revenue model is required; the checklist is a non-commercial, community health tool. Monetization is not established or necessary for this project. Skills and time to test: Basic clinical knowledge and data entry skills. Estimated time: 1-2 hours for training, 5-10 minutes per patient, 2 hours for data review. Not independently verified. Geographic availability and limits: Unverified analysis, not established facts; confirm before acting. Source trial context not specified; checklist can be adapted to any clinic with both assessment methods. Availability of scans and calculators must be checked locally. Legal and platform constraints to verify: Unverified analysis, not established facts; confirm before acting. Verify local privacy, data protection, and consent requirements. Do not collect identifiable health data without appropriate permissions. No legal advice provided. Current prices and platform terms: Unverified analysis, not established facts; confirm before acting. Checklist creation and use costs are unknown and not reported. No price or commercial terms checked. Local printing or digital access may incur minimal costs. Age, payments and eligibility checks: MLAIEL requires age 16 or older; external eligibility and payments are unverified. Minimum age for MLAIEL is 16; patient age eligibility for statin assessment must follow local clinical guidelines. No external payments or KYC required; eligibility unverified. Smallest low-cost validation test: Pilot the checklist in one clinic with 10-20 patients over one month, using only existing staff and materials. Review completion rate and feedback before broader use. Human responsibilities: Clinician or nurse fills out the checklist during routine patient visits, explains the process to patients, and records follow-up adherence information. AI contribution and limits: Optional: AI can help analyze anonymized checklist data for patterns, but is not required for initial pilot. No autonomous decision-making or clinical recommendations. Data and access needed: De-identified patient risk scores, scan results, statin recommendations, and adherence data. Consent required for any data collection. Data quality and privacy must be verified. Source-supported setting and capacity: Major trial challenges how doctors decide who really needs statins A study of nearly 5,800 adults found that heart scans measuring calcium buildup in the arteries led to the same observed rate of major cardiovascular events as traditional risk assessments, despite recommending statins to far fewer patients. Ordered steps and owners: 1. Adapt checklist template to local protocols. 2. Train clinician/nurse to use checklist. 3. Recruit up to 20 patients for pilot. 4. Complete checklist during visits. 5. Collect and review data after 30 days. Minimum resources and dependencies: Existing risk calculators, heart scan reports, paper or digital forms, and staff time. Confirm access to both assessment methods before starting. Costs and affordability unknowns: Actual costs for printing, staff time, and data review are unknown and require local estimates. No reported prices for checklist creation or use. How a newcomer can help: Clinician or nurse (primary operator), supervisor for oversight, and up to 20 adult patients. A beginner can assist with data entry under supervision. Pilot and success criteria: Proposed pilot target: At least 80% of eligible patient visits (n=20) completed with both methods recorded over 30 days. Compare number of statin recommendations and 1-month adherence rates. Baseline: current protocol. Success: 90% checklist completion and clear difference in recommendations documented. Risks and safeguards: Patient privacy, data entry errors, and workflow disruption. Checklist must not replace clinical judgment. No clinical decisions should be made solely based on the checklist. When to stop or change direction: If checklist completion rate falls below 50% or clinicians report significant workflow burden, the pilot will be paused and reviewed.